![Thomas Biancardi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Biancardi
Nessuna posizione attualmente
Storia della carriera di Thomas Biancardi
Precedenti posizioni note di Thomas Biancardi
Società | Posizione | Inizio | Fine |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - | - |
IVERIC BIO, INC. | Direttore operativo | 01/09/2007 | 31/01/2012 |
Contatto Relazioni con gli Investitori | 29/08/2013 | 14/01/2015 | |
Public Communications Contact | 01/09/2007 | - | |
Corporate Officer/Principal | 19/08/2013 | - | |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Direttore operativo | - | - |
Direttore Finanziario/CFO | - | - |
Formazione di Thomas Biancardi
New York University | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
IVERIC bio, Inc.
![]() IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- Thomas Biancardi
- Esperienza